Fuente: Fortune
A clinical trial failure and U. S. competition have been tough for the Danish pharmaceutical firm.
Leer en la Fuente
Noticias Relacionadas
Lista de Noticias
Weight loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult
Weight
Fortune
Hace 10h
